Drug Discovery
Top open-source Drug Discovery AI systems, agents, and MCP tools.
Discover and install verified Drug Discovery AI systems, autonomous agent skills, and Model Context Protocol servers on AIStoreHub. Reusable, security-scanned, and ready for 1-click execution in Cursor, Claude Code, and terminal workflows.
Available AI Systems & Skills (8)
Open in Advanced FilterAn AI co-scientist running on your desktop. Claude Science but better.
💊 AI Research Assistant for Accelerated Drug Discovery. 🦞
A curated collection of AI agent skills for biomedical research, covering genomics, proteomics, single-cell analysis, clinical AI, and protein design.
197 bioinformatics & life science skills for Claude Code and AI agents — BixBench 92.0% accuracy. RNA-seq, single-cell, drug discovery, proteomics, and more. Powers OmicsHorizon.
AI-powered biologics design campaign agent — multi-agent orchestration with BoltzGen, PXDesign, Protenix, and 200+ cloud tools. Antibodies, nanobodies, de novo binders, and beyond.
ScienceClaw is a personal research assistant built with LangChain DeepAgents and AIO Sandbox infrastructure, adopting a completely new architecture beyond OpenClaw. It offers stronger security, better transparency, and a more user-friendly experience.
Turn any AI agent into an AI Scientist. The #1 Agent Skills library for science, used by 250,000+ scientists worldwide. 177 ready-to-use validated skills plus 100+ scientific databases covering biology, chemistry, medicine, and drug discovery. Compatible with Cursor, Claude Code, Codex, Pi, Antigravity, and the open Agent Skills standard.
A curated, multilingual library of 182 installable AI agent skills for end-to-end academic research—spanning literature discovery, scientific writing, grant development, bioinformatics, drug discovery, clinical research, machine learning, and data analysis.
Build & Monetize for Drug Discovery
Have you created an autonomous agent, MCP server, or Claude Code skill for Drug Discovery? Publish it to AIStoreHub with dual-currency checkout (USD $ + INR ₹) and earn 85–90% net revenue.